awgldk
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Table
SPARQL
Graphs
1
1
Services
1
1
Assets
0
0
Insights
Schema
BETA
Class frequency
Class hierarchy
Q38907580-0DCEBC77-056B-4CDC-8E74-F3DD143ACE1B
Q38907580-0DCEBC77-056B-4CDC-8E74-F3DD143ACE1B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38907580-0DCEBC77-056B-4CDC-8E74-F3DD143ACE1B
The development of biomarkers to reduce attrition rate in drug discovery focused on oncology and central nervous system.
P2860
Q38907580-0DCEBC77-056B-4CDC-8E74-F3DD143ACE1B
BestRank
Statement
http://www.wikidata.org/entity/statement/Q38907580-0DCEBC77-056B-4CDC-8E74-F3DD143ACE1B
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
4a1b12e7ec676834380e6b6e34bcab0e6079e389
P2860
Role of KRAS and EGFR as biomarkers of response to erlotinib in National Cancer Institute of Canada Clinical Trials Group Study BR.21.